TGFB1 and neoplasm: These data suggest that by inhibiting TGF-β activation, αV knockout in anti-PD-1-treated tumours results in recruitment and expansion of CD8+ T cells, and subsequent induction of CD103 on TCR-engaged CTL as we previously reported48.